Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097617
Status:
COMPLETED
Last Update Posted:
2012-11-14
First Post:
2004-11-24
Brief Title:
A Study in Children With Growth Failure Due to Chronic Renal Insufficiency CRI or End Stage Renal Disease ESRD
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Study Overview
Official Title:
National Cooperative Growth Study NCGS of Nutropin AQ Nutropin and Protropin in Children With Growth Failure Due to Chronic Renal Insufficiency CRI or End Stage Renal Disease ESRD
Status:
COMPLETED
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a multicenter open-label observational postmarketing surveillance study that will collect information on the use of Genentech growth hormone GH preparations to treat children with CRI in the United States
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None